UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.243

Sortiert nach

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose

Translational psychiatry, 2016-10, Vol.6 (10), p.e920-e920

Seeman, P

2016

Volltextzugriff (PDF)

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors: implications for models of schizophrenia

Molecular psychiatry, 2002-09, Vol.7 (8), p.837-844

2002

Volltextzugriff (PDF)

Biallelic variants in the SORD gene are one of the most common causes of hereditary neuropathy among Czech patients

Scientific reports, 2021-04, Vol.11 (1), p.8443-8443, Article 8443

2021

Volltextzugriff (PDF)

Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits

Molecular psychiatry, 2016-11, Vol.21 (11), p.1561-1572

2016

Volltextzugriff (PDF)

Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics

Molecular psychiatry, 2005-09, Vol.10 (9), p.877-883

2005

Volltextzugriff (PDF)

Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors

Synapse (New York, N.Y.), 2015-04, Vol.69 (4), p.183-189

Seeman, Philip

2015

Volltextzugriff (PDF)

Enhanced dopamine function in DISC1‐L100P mutant mice: implications for schizophrenia

Genes, brain and behavior, 2010-10, Vol.9 (7), p.777-789

2010

Volltextzugriff (PDF)

High frequency of SH3TC2 mutations in Czech HMSN I patients

Clinical genetics, 2011-10, Vol.80 (4), p.334-345

2011

Volltextzugriff (PDF)

Lower urinary tract functions in a series of Charcot-Marie-Tooth neuropathy patients

Acta neurologica Scandinavica, 2014-05, Vol.129 (5), p.319-324

2014

Volltextzugriff (PDF)

Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

Molecular psychiatry, 1998-03, Vol.3 (2), p.123-134

1998

Volltextzugriff (PDF)

COX6A1 mutation causes axonal hereditary motor and sensory neuropathy - the confirmation of the primary report

Clinical genetics, 2016-04, Vol.89 (4), p.512-514

2016

Volltextzugriff (PDF)

Demyelinating Charcot–Marie–Tooth neuropathy associated with FBLN5 mutations

European journal of neurology, 2020-12, Vol.27 (12), p.2568-2574

2020

Volltextzugriff (PDF)

The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia

Genes, brain and behavior, 2007-10, Vol.6 (7), p.628-639

2007

Volltextzugriff (PDF)

Anti-hyperactivity medication : methylphenidate and amphetamine

Molecular psychiatry, 1998-09, Vol.3 (5), p.386-396

1998

Volltextzugriff (PDF)

Novel SBF2 mutations and clinical spectrum of Charcot‐Marie‐Tooth neuropathy type 4B2

Clinical genetics, 2018-11, Vol.94 (5), p.467-472

2018

Volltextzugriff (PDF)

HSMNR belongs to the most frequent types of hereditary neuropathy in the Czech Republic and is twice more frequent than HMSNL

Clinical genetics, 2016-08, Vol.90 (2), p.161-165

2016

Volltextzugriff (PDF)

Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

Psychopharmacologia, 2000-10, Vol.152 (2), p.174-180

2000

Volltextzugriff (PDF)

In Vivo Evidence for Dopamine-Mediated Internalization of D2-Receptors after Amphetamine: Differential Findings with [3H]Raclopride versus [3H]Spiperone

Molecular pharmacology, 2003-02, Vol.63 (2), p.456

2003

Volltextzugriff (PDF)

Increased expression of calcium/calmodulin-dependent protein kinase IIβ in frontal cortex in schizophrenia and depression

Synapse (New York, N.Y.), 2006-01, Vol.59 (1), p.61-68

2006

Volltextzugriff (PDF)

Mutations in HINT1 are one of the most frequent causes of hereditary neuropathy among Czech patients and neuromyotonia is rather an underdiagnosed symptom

Neurogenetics, 2015-01, Vol.16 (1), p.43-54

2015

Volltextzugriff (PDF)

Atypical Antipsychotics: Mechanism of Action

Canadian journal of psychiatry, 2002-02, Vol.47 (1), p.27-38

Seeman, Philip

2002

Volltextzugriff (PDF)

5. Electrophysiological features of peripheral and central nervous system in hereditary neuropathy Charcot Marie Tooth linked to X chromosome

Clinical neurophysiology, 2014-05, Vol.125 (5), p.e26-e26

2014

Volltextzugriff (PDF)

Dopamine receptor pharmacology

Trends in Pharmacological Sciences, 1994-07, Vol.15 (7), p.264-270

1994

Volltextzugriff (PDF)

An Update of Fast-Off Dopamine D 2 Atypical Antipsychotics

The American journal of psychiatry, 2005-10, Vol.162 (10), p.1984-1985

SEEMAN, PHILIP

2005

Volltextzugriff (PDF)

In Vivo Evidence for Dopamine-Mediated Internalization of D 2 -Receptors after Amphetamine: Differential Findings with [ 3 H]Raclopride versus [ 3 H]Spiperone

Molecular pharmacology, 2003-02, Vol.63 (2), p.456-462

2003

Volltextzugriff (PDF)

1 – 25 von 1.243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(965)
Mit Volltextzugriff
(1.089)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(642)
Life Sciences & Biomedicine
(521)
Humans
(444)
Animals
(268)
Male
(264)
Biological And Medical Sciences
(244)
Female
(228)
Medical Sciences
(163)
Aged
(133)
Adult
(126)
Middle Aged
(120)
Neurosciences & Neurology
(107)
Rats
(103)
Receptors, Dopamine - Metabolism
(101)
Fundamental And Applied Biological Sciences. Psychology
(99)
Neurosciences
(98)
Pharmacology & Pharmacy
(96)
Biochemistry & Molecular Biology
(76)
Psychiatry
(76)
In Vitro Techniques
(73)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors: implications for models of schizophrenia

Biallelic variants in the SORD gene are one of the most common causes of hereditary neuropathy among Czech patients

Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits

Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics

Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors

Enhanced dopamine function in DISC1‐L100P mutant mice: implications for schizophrenia

High frequency of SH3TC2 mutations in Czech HMSN I patients

Lower urinary tract functions in a series of Charcot-Marie-Tooth neuropathy patients

Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

COX6A1 mutation causes axonal hereditary motor and sensory neuropathy - the confirmation of the primary report

Demyelinating Charcot–Marie–Tooth neuropathy associated with FBLN5 mutations

The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia

Anti-hyperactivity medication : methylphenidate and amphetamine

Novel SBF2 mutations and clinical spectrum of Charcot‐Marie‐Tooth neuropathy type 4B2

HSMNR belongs to the most frequent types of hereditary neuropathy in the Czech Republic and is twice more frequent than HMSNL

Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

In Vivo Evidence for Dopamine-Mediated Internalization of D2-Receptors after Amphetamine: Differential Findings with [3H]Raclopride versus [3H]Spiperone

Increased expression of calcium/calmodulin-dependent protein kinase IIβ in frontal cortex in schizophrenia and depression

Mutations in HINT1 are one of the most frequent causes of hereditary neuropathy among Czech patients and neuromyotonia is rather an underdiagnosed symptom

Atypical Antipsychotics: Mechanism of Action

5. Electrophysiological features of peripheral and central nervous system in hereditary neuropathy Charcot Marie Tooth linked to X chromosome

Dopamine receptor pharmacology

An Update of Fast-Off Dopamine D 2 Atypical Antipsychotics

In Vivo Evidence for Dopamine-Mediated Internalization of D 2 -Receptors after Amphetamine: Differential Findings with [ 3 H]Raclopride versus [ 3 H]Spiperone

Suchergebnisse filtern